Semaglutide in Australia

What is semaglutide?

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist. By mimicking the body's native GLP-1 hormone it slows gastric emptying, increases satiety, and improves insulin sensitivity. It was originally developed by Novo Nordisk for type 2 diabetes and is now widely used for medically supervised weight management.

In Australia semaglutide is available as three ARTG-registered branded products — Wegovy (weekly injection, on-label for weight management), Ozempic (weekly injection, on-label for type 2 diabetes), and Rybelsus (daily oral tablet, on-label for type 2 diabetes). Compounded semaglutide is also lawful under TGA SAS-B when clinically justified for an individual patient.

Typical clinical indications

• Type 2 diabetes — glycaemic control (Ozempic, Rybelsus)
• BMI ≥30 — medically supervised weight management (Wegovy)
• BMI ≥27 with weight-related comorbidity (Wegovy)
• Maintenance after initial weight loss

Administration & titration

Wegovy and Ozempic: once-weekly subcutaneous injection (abdomen, thigh, or upper arm). Standard titration starts at 0.25 mg/week for 4 weeks and steps up every 4 weeks (0.5 → 1.0 → 1.7 → 2.4 mg for Wegovy). Most Wegovy patients find a clinically effective dose between 1.7 mg and 2.4 mg. Slower titration meaningfully reduces gastrointestinal side effects.

Cautions and contraindications

Not prescribed in pregnancy or breastfeeding, with personal/family history of medullary thyroid carcinoma or MEN-2 syndrome, with prior pancreatitis, or with active gallbladder disease. Use caution with insulin or sulfonylureas (hypoglycaemia risk). Stop 1 week before elective surgery requiring general anaesthesia.

Wegovy vs Ozempic vs Rybelsus

All three are semaglutide. The right choice depends on indication, format preference, and cost — reviewed at consultation.

For the dual-agonist alternative, see tirzepatide Australia. For the triple-agonist investigational option, see retatrutide Australia.

How to get semaglutide prescribed in Australia

1. 1. Free 5-minute pre-qualification

   Answer screening questions about BMI, medical history, and current medications. Instant suitability check.

2. 2. $99 telehealth consult

   Video or phone consult with an AHPRA-registered Australian doctor. They review eligibility, discuss Wegovy vs Ozempic vs Rybelsus, and confirm titration.

3. 3. Script issued (24–48 hours)

   Private script for Wegovy, Ozempic or Rybelsus to any Australian pharmacy, or a TGA SAS-B notification for compounded semaglutide to a TGA-licensed compounding pharmacy.

4. 4. Cold-chain dispense (2–4 business days)

   Pharmacy ships cold-chain Mon–Wed. Includes pens, syringes if needed, alcohol swabs, and a starter guide.

Semaglutide Australia — FAQs

Is semaglutide legal in Australia?

Yes. Semaglutide is fully legal in Australia and ARTG-registered as three branded products: Ozempic (weekly injection, on-label for type 2 diabetes), Wegovy (weekly injection, on-label for weight management), and Rybelsus (daily oral tablet, on-label for type 2 diabetes). All require a prescription from an AHPRA-registered Australian doctor and are dispensed at any Australian pharmacy. Compounded semaglutide is also lawful under TGA SAS-B when prescribed for an individual patient and dispensed by a TGA-licensed Australian compounding pharmacy.

Ozempic vs Wegovy vs Rybelsus — what's the difference?

All three contain semaglutide. Ozempic and Wegovy are weekly subcutaneous injections; Rybelsus is a daily oral tablet. Ozempic is ARTG-registered on-label for type 2 diabetes (doses 0.25–2.0 mg/week); Wegovy is ARTG-registered on-label for weight management (doses 0.25–2.4 mg/week); Rybelsus is on-label for type 2 diabetes only (3–14 mg/day). For weight loss, Wegovy is the on-label product. Using Ozempic off-label for weight loss is possible but TGA has asked prescribers to prioritise diabetic patients due to supply pressure.

How do I get semaglutide prescribed in Australia?

Book a telehealth consult with an AHPRA-registered Australian doctor (PeptideDoctorAU initial consult is $99). The doctor reviews your eligibility, BMI, comorbidities and baseline pathology if needed, then writes a private script for Wegovy, Ozempic, or Rybelsus (or a TGA SAS-B notification for compounded semaglutide where clinically justified). Scripts are typically issued within 24–48 hours and dispensed by cold-chain shipping or local pharmacy pickup.

How much does semaglutide cost in Australia per month?

As a 2026 guide: Wegovy is approximately AUD $460–$520/month on a private script depending on dose. Ozempic is approximately AUD $130/month on the PBS for eligible type 2 diabetes patients, or roughly $300/month on a private script for off-label weight-loss use (subject to availability). Rybelsus is approximately AUD $200–$280/month on a private script. Compounded semaglutide under SAS-B varies — typically AUD $250–$450/month per case.

Am I eligible for semaglutide for weight loss in Australia?

Australian prescribers generally consider Wegovy for adults (18+) with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea). Final eligibility is a clinical decision at consultation. Semaglutide is not prescribed in pregnancy, breastfeeding, with personal/family history of medullary thyroid cancer or MEN-2, or with active pancreatitis.

How fast does semaglutide work?

Most patients notice reduced appetite in the first 1–2 weeks. Measurable weight loss is typical within 4–8 weeks. STEP trial data shows average weight loss of around 14–17% of body weight at the 2.4 mg Wegovy dose over 68 weeks. Slow titration (starting at 0.25 mg/week and stepping up every 4 weeks) is the single biggest factor in tolerability and long-term success.

What are the side effects of semaglutide?

The most common side effects are gastrointestinal during dose titration: nausea, reflux, constipation, diarrhoea, decreased appetite. These usually settle within 1–2 weeks at each new dose step. Less common but more serious risks include pancreatitis, gallbladder disease, and severe hypoglycaemia (especially when combined with insulin or sulfonylureas). Discuss your full medical history with your prescriber.

Can I get semaglutide on telehealth?

Yes. Telehealth semaglutide prescribing is a routine pathway used by AHPRA-registered Australian doctors. The consult is by video or phone from anywhere in Australia. If baseline pathology is required, you visit any local collection centre. Cold-chain delivery to your address typically takes 2–4 business days after dispense.

Medically reviewed by the PeptideDoctorAU Medical Review Panel — last reviewed 29 May 2026. See the panel.